Atara Biotherapeutics Valuation
| ATRA Stock | USD 12.12 0.65 5.67% |
At this time, the firm appears to be undervalued. Atara Biotherapeutics shows a prevailing Real Value of $12.92 per share. The current price of the firm is $12.12. Our model approximates the value of Atara Biotherapeutics from analyzing the firm fundamentals such as profit margin of (2.90) %, and Return On Equity of -20.15 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Atara Biotherapeutics' valuation include:
Price Book 1.9674 | Enterprise Value 52.5 M | Enterprise Value Ebitda (0.35) | Price Sales 1.119 | Enterprise Value Revenue 0.5229 |
Undervalued
Today
Please note that Atara Biotherapeutics' price fluctuation is slightly risky at this time. Calculation of the real value of Atara Biotherapeutics is based on 3 months time horizon. Increasing Atara Biotherapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Atara Biotherapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Atara Stock. However, Atara Biotherapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 12.12 | Real 12.92 | Target 14.72 | Hype 11.29 |
The real value of Atara Stock, also known as its intrinsic value, is the underlying worth of Atara Biotherapeutics Company, which is reflected in its stock price. It is based on Atara Biotherapeutics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Atara Biotherapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Atara Biotherapeutics helps investors to forecast how Atara stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Atara Biotherapeutics more accurately as focusing exclusively on Atara Biotherapeutics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Atara Biotherapeutics' intrinsic value based on its ongoing forecasts of Atara Biotherapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Atara Biotherapeutics' closest peers. If more than one evaluation category is relevant for Atara Biotherapeutics we suggest using both methods to arrive at a better estimate.
Atara Biotherapeutics Cash |
|
Atara Valuation Trend
Comparing Atara Biotherapeutics' enterprise value against its market capitalization is a good way to estimate the value of Atara Biotherapeutics uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Atara Biotherapeutics Total Value Analysis
Atara Biotherapeutics is presently projected to have valuation of 52.52 M with market capitalization of 69.81 M, debt of 57.87 M, and cash on hands of 331.31 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Atara Biotherapeutics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
52.52 M | 69.81 M | 57.87 M | 331.31 M |
Atara Biotherapeutics Investor Information
About 22.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.97. Some equities with similar Price to Book (P/B) outperform the market in the long run. Atara Biotherapeutics recorded a loss per share of 25.32. The entity had not issued any dividends in recent years. The firm had 1:25 split on the 20th of June 2024. Based on the key indicators related to Atara Biotherapeutics' liquidity, profitability, solvency, and operating efficiency, Atara Biotherapeutics is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Atara Biotherapeutics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Atara Biotherapeutics has an asset utilization ratio of 5.18 percent. This suggests that the Company is making $0.0518 for each dollar of assets. An increasing asset utilization means that Atara Biotherapeutics is more efficient with each dollar of assets it utilizes for everyday operations.Atara Biotherapeutics Ownership Allocation
The market capitalization of Atara Biotherapeutics is $69.81 Million. Over half of Atara Biotherapeutics' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Atara Biotherapeutics Profitability Analysis
The company reported the previous year's revenue of 8.57 M. Net Loss for the year was (276.13 M) with profit before overhead, payroll, taxes, and interest of 63.57 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Atara Biotherapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Atara Biotherapeutics and how it compares across the competition.
About Atara Biotherapeutics Valuation
The stock valuation mechanism determines Atara Biotherapeutics' current worth on a weekly basis. Our valuation model uses a comparative analysis of Atara Biotherapeutics. We calculate exposure to Atara Biotherapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Atara Biotherapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -313 K | -297.4 K | |
| Pretax Profit Margin | (32.21) | (33.82) | |
| Operating Profit Margin | (32.19) | (33.80) | |
| Net Loss | (32.21) | (33.82) | |
| Gross Profit Margin | (0.04) | (0.03) |
Atara Biotherapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 4.2 M |
Atara Biotherapeutics Current Valuation Indicators
Valuation refers to the process of determining the present value of Atara Biotherapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Atara we look at many different elements of the entity such as Atara's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Atara Biotherapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Atara Biotherapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Atara Biotherapeutics' worth.Complementary Tools for Atara Stock analysis
When running Atara Biotherapeutics' price analysis, check to measure Atara Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atara Biotherapeutics is operating at the current time. Most of Atara Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Atara Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atara Biotherapeutics' price. Additionally, you may evaluate how the addition of Atara Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |